Published date: 17 August 2018

Last edited date: 17 August 2018

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 23 March 2016

Contract summary

Industry

  • Disposable non-chemical medical consumables and haematological consumables - 33141000

  • Medicinal products for the blood and blood-forming organs - 33621000

Location of contract

Any region

Value of contract

£3,375,000 to £4,124,999.80

Procurement reference

CM/PHS/16/5501

Published date

17 August 2018

Closing date

23 March 2016

Contract start date

1 July 2016

Contract end date

31 January 2019

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

NHS National framework agreement for the supply of Human Cell Line Recombinant Factor VIII products. The framework will commence on 1st July 2016 to 31st March 2017, with options to extend for up to a further 39 months. Please refer to the ITO, Document No.05d for a list of Participating Authorities.

More information

Attachments

  • Human Cell Line rFVIII.zip
  • Invitation to tender documents - NHS National Framework Agreement for the supply of Human Cell Line Recombinant Factor VIII products

Additional text

The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England, Wales, Scotland and Northern Ireland. The framework may also be used by private sector contractors and agents working on behalf of the above. Please refer to Document 05d in the ITO documents for the list of Participating Authorities

Award information

Awarded date

2 June 2016

Contract start date

1 July 2016

Contract end date

31 March 2017

Total value of contract

£3,750,000

This contract was awarded to 1 supplier.

Please refer to "Parties appointed to the framework agreement"

Address

WA7 2ES

Reference

None

Supplier is SME?

No

Supplier is VCSE?

No

Attachments

About the buyer

Address

Commercial Medicines Unit
2nd Floor, Rutland House,
Runcorn, Cheshire
WA7 2ES
England

Email

laura.boyle@dh.gsi.gov.uk